Unknown

Dataset Information

0

Antimicrobial Peptide Induced-Stress Renders Staphylococcus aureus Susceptible to Toxic Nucleoside Analogs.


ABSTRACT: Cationic antimicrobial peptides (AMPs) are active immune effectors of multicellular organisms and are also considered as new antimicrobial drug candidates. One of the problems encountered when developing AMPs as drugs is the difficulty of reaching sufficient killing concentrations under physiological conditions. Here, using pexiganan, a cationic peptide derived from a host defense peptide of the African clawed frog and the first AMP developed into an antibacterial drug, we studied whether sub-lethal effects of AMPs can be harnessed to devise treatment combinations. We studied the pexiganan stress response of Staphylococcus aureus at sub-lethal concentrations using quantitative proteomics. Several proteins involved in nucleotide metabolism were elevated, suggesting a metabolic demand. We then show that Staphylococcus aureus is highly susceptible to antimetabolite nucleoside analogs when exposed to pexiganan, even at sub-inhibitory concentrations. These findings could be used to enhance pexiganan potency while decreasing the risk of resistance emergence, and our findings can likely be extended to other antimicrobial peptides.

SUBMITTER: Rodriguez-Rojas A 

PROVIDER: S-EPMC7550632 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antimicrobial Peptide Induced-Stress Renders <i>Staphylococcus aureus</i> Susceptible to Toxic Nucleoside Analogs.

Rodríguez-Rojas Alexandro A   Nath Arpita A   El Shazely Baydaa B   Santi Greta G   Kim Joshua Jay JJ   Weise Christoph C   Kuropka Benno B   Rolff Jens J  

Frontiers in immunology 20200929


Cationic antimicrobial peptides (AMPs) are active immune effectors of multicellular organisms and are also considered as new antimicrobial drug candidates. One of the problems encountered when developing AMPs as drugs is the difficulty of reaching sufficient killing concentrations under physiological conditions. Here, using pexiganan, a cationic peptide derived from a host defense peptide of the African clawed frog and the first AMP developed into an antibacterial drug, we studied whether sub-le  ...[more]

Similar Datasets

2008-04-07 | GSE8400 | GEO
2008-04-06 | E-GEOD-8400 | biostudies-arrayexpress
| S-EPMC5939666 | biostudies-literature
| S-EPMC6553709 | biostudies-literature
| S-EPMC3025174 | biostudies-literature
| S-EPMC5161045 | biostudies-literature
| S-EPMC4593430 | biostudies-literature
| S-EPMC5009239 | biostudies-literature
| S-EPMC6138395 | biostudies-literature
| S-EPMC10544327 | biostudies-literature